Opendata, web and dolomites


Progressing a non-antibiotic antimicrobial treatment for Bovine Mastitis towards market - PanaMast

Total Cost €


EC-Contrib. €






 PanaMast project word cloud

Explore the words cloud of the PanaMast project. It provides you a very rough idea of what is the project "PanaMast" about.

wastage    ahead    sustainable    global    stage    roadmap    supports    underpin    plan    product    regulatory    urgently    2020    innovation    annually    mastitis    30    bovine    successfully    infectious    farmers    ineffective    solutions    relationships    profitability    launch    culling    designed    ireland    environmental    40bn    financial    resistant    budget    trl7    dairy    world    medicine    resistance    health    economically    outcomes    herd    antimicrobials    veterinary    reduce    disease    antibiotic    sale    food    commercial    panamast    galway    wwh    killing    trl8    150    lc    panamasttm    gains    solution    superior    treatment    performance    progress    innovative    bacteria    cows    industry    rendering    animal    track    commercialisation    first    strategic    sites    mrsa    markets    antibiotics    westway    crisis    milk    breakthrough    clinical    company    treatments    allowed    market    quality    inducing    detailing    farms    safe    schedule    assist   

Project "PanaMast" data sheet

The following table provides information about the project.


Organization address
city: GALWAY
postcode: H91
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website
 Total cost 3˙549˙237 €
 EC max contribution 2˙484˙466 € (70%)
 Programme 1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2019-05-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SLAINTE BEOGA TEORANTA IE (GALWAY) coordinator 2˙484˙466.00


 Project objective

The world is facing an antibiotics crisis, with resistant bacteria rendering current treatments ineffective. Novel, effective solutions are urgently required for this $40bn global market. Westway Health (WWH) is based in Galway, Ireland, and is on track to become a leading veterinary antimicrobials company in the EU. It has developed an innovative, non-antibiotic technology, effective at killing all bacteria, including antibiotic-resistant bacteria like MRSA, while not inducing resistance. WWH’s lead product in development is PanaMastTM LC, a breakthrough treatment of bovine mastitis, the most economically important infectious disease affecting the dairy industry. PanaMastTM LC will represent a step change in the way that dairy farmers manage mastitis, which affects 30% of the herd annually. It will: 1. Be the world’s first non-antibiotic medicine for mastitis, offering superior clinical outcomes and significant financial gains to end-users (€150/case); 2. Reduce wastage of milk and culling of cows; (3) Improve profitability and environmental performance on European farms and dairy processing sites. The innovation directly addresses the major global problem of antibiotic resistance, while providing a sustainable animal health solution that supports production of safe and high quality food. The Phase 1 PanaMast project was successfully completed ahead of schedule and on budget. It allowed WWH to: 1. Develop a regulatory roadmap detailing all steps required to progress from current stage of development (TRL7) to first sale of commercial product (TRL8); 2. Develop a robust commercial exploitation plan for PanaMastTM LC in EU and global markets; 3. Establish key strategic relationships to assist commercialisation of PanaMastTM LC The Phase 1 results underpin this proposed project. The Phase 2 activities (pre-commercialisation/product development/product launch and commercialisation) are designed to ensure market launch and sale of PanaMastTM LC in the EU at TRL8 by 2020


List of deliverables.
Project website Websites, patent fillings, videos etc. 2019-04-18 14:42:25

Take a look to the deliverables list in detail:  detailed list of PanaMast deliverables.


year authors and title journal last update
List of publications.
2018 Lilit Tonoyan, Aoife Boyd, Gerard T.A. Fleming, Ruairi Friel, Carol M. Gately, Paul H. Mc Cay, Vincent O\'Flaherty
In vitro comparative cytotoxicity study of a novel biocidal iodo-thiocyanate complex
published pages: 264-273, ISSN: 0887-2333, DOI: 10.1016/j.tiv.2018.03.014
Toxicology in Vitro 50 2019-06-11
2017 Lilit Tonoyan, Gerard T. A. Fleming, Paul H. Mc Cay, Ruairi Friel, Vincent O\'Flaherty
Antibacterial Potential of an Antimicrobial Agent Inspired by Peroxidase-Catalyzed Systems
published pages: , ISSN: 1664-302X, DOI: 10.3389/fmicb.2017.00680
Frontiers in Microbiology 8 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PANAMAST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PANAMAST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)

Stoock (2018)

An Innovative Integrated Field Sensor system providing a precise farming tool to reduce productioncosts and water wastage.

Read More  

TEST4ALL (2018)


Read More  

FucoPol (2017)

An innovative bio-based platform for the cost-competitive production of L-fucose, a building block for Human Milk Oligosaccharides (HMOs).

Read More